MedTrace Logo

Effectiveness of SMS Nudging to Increase Coverage of Influenza Vaccination Among the Elderly

NCT06486766 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000000

Last updated 2024-08-07

No results posted yet for this study

Summary

The trial will investigate to what extent SMS reminders for influenza vaccination increases coverage of influenza vaccination among elderly from the majority population, and among elderly from immigrant groups with low vaccination coverage

Conditions

Interventions

BEHAVIORAL

Norwegian SMS

Individuals receive a SMS in Norwegian language at the start of the influenza season, to remind them they are recommended to get the influenza vaccine. This intervention arm is applicable to all three populations (general population, immigrants born in Poland, immigrants born in Ukraine)

BEHAVIORAL

Polish/Ukrainian SMS

Individuals receive an SMS in the official language of their native country (i.e., Polish or Ukrainian) at the start of the influenza season, to remind them they are recommended to get the influenza vaccine. This intervention arm is only applicable to the two immigrant populations (immigrants born in Poland, immigrants born in Ukraine)

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • Finnish Institute for Health and Welfare

    collaborator OTHER_GOV

  • University of Turku

    collaborator OTHER

  • University Hospital, Akershus

    collaborator OTHER

  • Norwegian Institute of Public Health

    lead OTHER_GOV

Principal Investigators

  • Bo T Hansen, PhD · Norwegian Institute of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-31
Primary Completion
2026-01-31
Completion
2026-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06486766 on ClinicalTrials.gov